About Impact Laboratories
Impact Laboratories is a private company based in Wilmington, Delaware, incorporated in 2023 in Delaware. It has reported $4,650,524 raised in two offerings on Form D since May 2024. Its chief executive is James Connelly.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Aug 25, 2026 | $875,000of $1.5M target | 6 | $145K | EquityRule 506(b) | Form D ↗ |
| Apr 24, 2024 | May 8, 2024amended Dec 17, 2024 | $3,775,524of $5.0M target | 13 | $290K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, two offerings | $4,650,524 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Impact Laboratories's Form D filed Aug 25, 2026.
DB
David Beeghly
Director
SW
Sam Wright
Executive officer
JC
James Connelly
CEO and director
AZ
Adam Zirkin
Director
NL